NeurogesX
18:19 :
NeurogesX picks former Poniard boss as president, CEO -
Former Poniard Pharmaceuticals CEO Ron Martell replaced the retired Tony DiTonno as president and CEO of pain treatment developer NeurogesX Inc. Martell’s base salary is $460,000, compared to a 2010 base salary of $440,214 at Poniard. ...
09:58 :
NeurogesX soars on drug update -
BOSTON (MarketWatch) -- Shares of NeurogesX Inc. soared 21% to stand at $3.23 early Thursday following news that it has completed enrollment in a Phase II clinical trial for its drug NGX-1998, a topical formulation of the pain reliever ...
actualidad NeurogesX -